Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celso Arango

Showing results (61-70 of 570) with videos related to

Pageof 57
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|April 14, 2025
Responsiveness of European countries to the population mental health needs: a cross-national comparison studyCelso Arango, Andrea Fiorillo, Geert Dom, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 12, 2011
Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS studyCelso Arango, Julio Bobes, Brian Kirkpatrick, et al.
European Child & Adolescent Psychiatry|November 24, 2019
Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysisCelso Arango, Daisy Ng-Mak, Elaine Finn, et al.
Schizophrenia Bulletin|April 4, 2025
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as an Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE-2) in Patients With Predominant Negative SymptomsDragana Bugarski-Kirola, I-Yuan Liu, Celso Arango, et al.
The International Journal of Neuropsychopharmacology|June 3, 2017
Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-AnalysisDavid Fraguas, Covadonga M Díaz-Caneja, Alberto Rodríguez-Quiroga, et al.
BMJ Mental Health|November 25, 2023
Socioeconomic status and severe mental disorders: a bidirectional multivariable Mendelian randomisation studyÁlvaro Andreu-Bernabeu, Javier González-Peñas, Celso Arango, et al.
Biological Psychiatry|October 6, 2007
Nonverbal delayed recognition in the relatives of schizophrenia patients with or without schizophrenia spectrumOlalla Robles, Teresa Blaxton, Helene Adami, et al.
The International Journal of Neuropsychopharmacology|November 30, 2012
Polypharmacy with antidepressants in children and adolescentsCovadonga M Díaz-Caneja, Ana Espliego, Mara Parellada, et al.
The American Journal of Psychiatry|August 6, 2003
The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumesCelso Arango, Alan Breier, Robert McMahon, et al.
Schizophrenia Research|January 4, 2015
Progressive brain changes in children and adolescents with early-onset psychosis: A meta-analysis of longitudinal MRI studiesDavid Fraguas, Covadonga M Díaz-Caneja, Laura Pina-Camacho, et al.
Pageof 57

Showing results (61-70 of 570) with videos related to

Sort By:
Pageof 57
European Psychiatry : the Journal of the Association of European Psychiatrists|April 14, 2025
Responsiveness of European countries to the population mental health needs: a cross-national comparison studyCelso Arango, Andrea Fiorillo, Geert Dom, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 12, 2011
Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: findings from the CLAMORS studyCelso Arango, Julio Bobes, Brian Kirkpatrick, et al.
European Child & Adolescent Psychiatry|November 24, 2019
Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysisCelso Arango, Daisy Ng-Mak, Elaine Finn, et al.
Schizophrenia Bulletin|April 4, 2025
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as an Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE-2) in Patients With Predominant Negative SymptomsDragana Bugarski-Kirola, I-Yuan Liu, Celso Arango, et al.
The International Journal of Neuropsychopharmacology|June 3, 2017
Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-AnalysisDavid Fraguas, Covadonga M Díaz-Caneja, Alberto Rodríguez-Quiroga, et al.
BMJ Mental Health|November 25, 2023
Socioeconomic status and severe mental disorders: a bidirectional multivariable Mendelian randomisation studyÁlvaro Andreu-Bernabeu, Javier González-Peñas, Celso Arango, et al.
Biological Psychiatry|October 6, 2007
Nonverbal delayed recognition in the relatives of schizophrenia patients with or without schizophrenia spectrumOlalla Robles, Teresa Blaxton, Helene Adami, et al.
The International Journal of Neuropsychopharmacology|November 30, 2012
Polypharmacy with antidepressants in children and adolescentsCovadonga M Díaz-Caneja, Ana Espliego, Mara Parellada, et al.
The American Journal of Psychiatry|August 6, 2003
The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumesCelso Arango, Alan Breier, Robert McMahon, et al.
Schizophrenia Research|January 4, 2015
Progressive brain changes in children and adolescents with early-onset psychosis: A meta-analysis of longitudinal MRI studiesDavid Fraguas, Covadonga M Díaz-Caneja, Laura Pina-Camacho, et al.
Pageof 57